The dydrogesterone and FSH protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation in IVF/ICSI cycle

被引：0
|
作者：
Gurbuz, A. S. [1 ]
Gode, F. [2 ]
机构：
[1] Novafertil IVF Ctr, Obstet & Gynecol, Konya, Turkey
[2] Bahcesehir Univ, Obstet & Gynecol, Istanbul, Turkey
来源：
HUMAN REPRODUCTION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-240
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, Xiuxian
    Ye, Hongjuan
    Fu, Yonglun
    [J]. MEDICINE, 2016, 95 (28)
  • [2] The usage of Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, X.
    Fu, Y.
    [J]. HUMAN REPRODUCTION, 2016, 31 : 420 - 421
  • [3] Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
    Sun, Bo
    Ma, Yujia
    Li, Lu
    Hu, Linli
    Wang, Fang
    Zhang, Yile
    Dai, Shanjun
    Sun, Yingpu
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 11
  • [4] The role of Loratadin in prevention of ovarian hyperstimulation syndrome in patients undergoing IVF/ICSI cycles
    Madani, T.
    Ashrafi, M.
    Khafri, S.
    Irani, S.
    [J]. HUMAN REPRODUCTION, 2007, 22 : I146 - I146
  • [5] Does the phenotype of polycystic ovary syndrome influence the ovarian response to controlled ovarian hyperstimulation for IVF?
    Robin, G.
    Grysole, C.
    Uk, A.
    Barbotin, A. L.
    Decanter, C.
    Dewailly, D.
    [J]. HUMAN REPRODUCTION, 2018, 33 : 466 - 467
  • [6] Efficiency of an ovarian stimulation protocol combining clomiphene citrate and FSH in patients with hyperstimulation in a previous IVF cycle
    Geenen, E.
    Bots, R. S. G. M.
    Smeenk, J. M. J.
    [J]. HUMAN REPRODUCTION, 2012, 27
  • [7] C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle
    Orvieto, R
    Chen, R
    Ashkenazi, J
    Ben-Harush, A
    Bar, J
    Fisch, B
    [J]. HUMAN REPRODUCTION, 2004, 19 (02) : 357 - 359
  • [8] Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
    Huang, Ying
    Zhao, Yong
    Yan, Ling
    Chuai, Yun-Hai
    Liu, Ling-Ling
    Chen, Yi
    Li, Min
    Wang, Ai-Ming
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [9] Management for controlled ovarian hyperstimulation for an unusual "hyporesponsiveness" to FSH and clomiphene in patients with polycystic ovarian disease.
    Tang, WL
    Chien, LW
    Chen, CS
    Chen, PH
    Tzeng, CR
    [J]. FERTILITY AND STERILITY, 2005, 84 : S305 - S305
  • [10] Methylprednisolone for prevention of ovarian hyperstimulation syndrome in patients with polycystic ovarian syndrome undergoing in-vitro fertilisation: a randomised controlled trial
    Yeganeh, Ladan Mohammadi
    Moini, Ashraf
    Shiva, Marzieh
    Mirghavam, Naimeh
    Lankarani, Narges Bagheri
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 38 (02) : 241 - 246
12345